Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

Filgotinib, an oral Janus kinase‐1 preferential inhibitor, is approved in Europe and Japan for adults with rheumatoid arthritis. Patients with rheumatoid arthritis are at higher risk of cardiovascular morbidity/mortality; thus, it is important to understand potential drug‐drug interactions of filgot...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Kacey, Nelson, Cara H., Gong, Qi, Alani, Muhsen, Tarnowski, Thomas, Othman, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293227/
https://www.ncbi.nlm.nih.gov/pubmed/34468080
http://dx.doi.org/10.1002/cpdd.1015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293227/
https://www.ncbi.nlm.nih.gov/pubmed/34468080
http://dx.doi.org/10.1002/cpdd.1015

Ejemplares similares